تعداد نشریات | 20 |
تعداد شمارهها | 1,149 |
تعداد مقالات | 10,518 |
تعداد مشاهده مقاله | 45,415,541 |
تعداد دریافت فایل اصل مقاله | 11,291,343 |
Comparative analysis of P63, Maspin and Matrix Metalloproteinase 2 Expression in Mucoepidermoid Carcinoma and Adenoid Cystic Carcinoma of Salivary Glands | ||
Journal of Dentistry | ||
مقاله 3، دوره 21، شماره 2 - شماره پیاپی 67، شهریور 2020، صفحه 95-101 اصل مقاله (674.44 K) | ||
نوع مقاله: Original Article | ||
شناسه دیجیتال (DOI): 10.30476/dentjods.2019.77868.0 | ||
نویسندگان | ||
Nasim Taghavi1؛ Farzad Yazdani2؛ Alireza Akbarzadeh Baghban3؛ Soudabeh Sargolzaei1؛ Parisa Kardouni Khozestani* 4 | ||
1Dept. of Oral & Maxillofacial Pathology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | ||
2Dept. of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. | ||
3Proteomics Research Center, Dept. of Basic Science, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | ||
4Dept. of Oral and Maxillofacial Pathology, Dental School, Anzali International Campus, Guilan university of Medical Sciences, Rasht, Iran. | ||
چکیده | ||
Statement of the Problem: The tumor suppressor role of myoepithelial cells and related mechanisms in breast tumors are well understood. However, the role of these cells in salivary glands tumors is debatable. Purpose: The present study was designed to determine the expression of p63, Maspin and Matrix metalloproteinase 2 (MMP-2) in mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ADCC) of salivary glands due to various cellular differentiation and structure. The association between the expression of these markers and clinicopathologic features and myoepithelial differentiation were also evaluated. Materials and Method: P63, Maspin and MMP-2 expression were immunohistochemically studied in 67 cases including35 cases of MEC and 32 cases of ADCC. The smooth muscle actin (SMA) staining was also applied to confirm the presence of myoepithelial differentiation. Data was analyzed using Chi-square test, Mann-Whitney U test and t-test. Results: The expression of p63 (p = 0.009) and Maspin (p = 0.012) significantly differed between the study groups.P63 positive cells in MEC were negative for SMA staining in contrast to ADCC. Furthermore, the expression of P63 (p = 0.045) and Maspin (p = 0.019) significantly and inversely correlated with histologic grade in ADCC. Likewise, positive significant correlation was detected between histologic grade and expression of P63 (p = 0.018) and MMP-2 (p = 0.003) in MEC samples. Conclusion: Ourfindings showed thatMEC is devoid of myoepithelial cells. The difference in expression of P63 and Maspin in ADCC and MEC highlighted the role and presence of myoepithelial cells in ADCC. Indeed, the high expression of P63 and Maspin in well differentiated ADCCs suggests the tumor suppressor effect of myoepithelial cells. Considering the association between the evaluated markers and histological grade, p63 in both tumors, Maspin in ADCC and MMP-2 in MEC may be efficient predictors of clinical behavior. | ||
کلیدواژهها | ||
Mucoepidermoid Carcinoma؛ Adenoid Cystic Carcinoma؛ P63؛ Maspin؛ Matrix Metalloproteinase | ||
سایر فایل های مرتبط با مقاله
|
||
مراجع | ||
1. Bilal H, Handra-Luca A, Bertrand JC, Fouret PJ. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem. 2003; 51: 133–139. [PubMed] [Google Scholar]
2. Savera AT, Zarbo RJ. Defining the role of myoepithelium in salivary gland neoplasia. Adv Anat Pathol. 2004; 11: 69–85. [PubMed] [Google Scholar]
3. Sternlicht MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med Hypotheses. 1997; 48: 37–46. [PubMed] [Google Scholar]
4. Taghavi N, Sargolzaei S, Mashhadiabbas F, Akbarzadeh A, Kardouni P. Salivary Gland Tumors: A 15- year Report from Iran. Turk Patoloji Derg. 2016; 32: 35–39. [PubMed] [Google Scholar]
5. Fonseca FP, de Andrade BA, Lopes MA, Pontes HA, Vargas PA, de Almeida OP. P63 expression in papillary cystadenoma and mucoepidermoid carcinoma of minor salivary glands. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 115: 79–86. [PubMed] [Google Scholar]
6. Regezi JA, Zarbo RJ, Batsakis JG. Immunoprofile of mucoepidermoid carcinoma of minor salivary glands. Oral Surg Oral Med Oral Pathol. 1991; 71: 189–192. [PubMed] [Google Scholar]
7. Foschini MP, Marucci G, Eusebi V. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch. 2002; 440: 536–542. [PubMed] [Google Scholar]
8. Ramer N, Wu H, Sabo E, Ramer Y, Emanuel P, Orta L, et al. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Cancer. 2010; 116: 77–83. [PubMed] [Google Scholar]
9. Speight PM, Barrett AW. Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg. 2009; 47: 587–593. [PubMed] [Google Scholar]
10. Lo Muzio L, Campisi G, Farina A, Rubini C, Pastore L, Giannone N. Effect of p63 expression on survival in oral squamus cell carcinoma. Cancer Invest. 2007; 25: 464–469. [PubMed] [Google Scholar]
11. El-Gendi S, Abu-Sheasha G. Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma. Pathol Oncol Res. 2018; 24: 309–322. [PubMed] [Google Scholar]
12. Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng SJ, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene. 2000; 19: 2398–2403. [PubMed] [Google Scholar]
13. Pandey PR, Saidou J, Watabe K. Role of myoepithelial cells in breast tumor progression. Front Biosci (Landmark Ed) . 2010; 15: 226–236. [PMC free article] [PubMed] [Google Scholar]
14. Martin MT, Altemani A, Freitas L, Araújo VC. Maspin expression in carcinoma ex pleomorphic adenoma. J Clin Pathol. 2005; 58: 1311–1314. [PMC free article] [PubMed] [Google Scholar]
15. Nagel H, Laskawi R, Wahlers A, Hemmerlein B. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland. Histopathology. 2004; 44: 222–231. [PubMed] [Google Scholar]
16. Zhou X, Huang S, Jiang L, Zhang S, Li W, Chen Z, Zhang D. Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis. Oncol Lett. 2014; 7: 1549–1555. [PMC free article] [PubMed] [Google Scholar]
17. Elahi M, Rakhshan V, Ghasemian NT, Moshref M. Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9[MMP-9] in oral squamous cell carcinoma. Biomarkers. 2012; 17: 21–27. [PubMed] [Google Scholar]
18. Sternlicht MD, Safarians S, Rivera SP, Barsky SH. Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest. 1996; 74: 781–796. [PubMed] [Google Scholar]
19. Douglas R. Gnepp. Diagnostic surgical pathology of the head and neck. 1th ed . Philadelphia : Saunders Inc; 2009. [Google Scholar]
20. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001; 25: 835–845. [PubMed] [Google Scholar]
21. Sams RN, Gnepp DR. P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Head Neck Pathol. 2013; 7: 64–68. [PMC free article] [PubMed] [Google Scholar]
22. Edwards PC, Bhuiya T, Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 97: 613–619. [PubMed] [Google Scholar]
23. Prasad ML, Barbacioru CC, Rawal YB, Husein O, Wen P. Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Mod Pathol. 2008; 21: 105–114. [PubMed] [Google Scholar]
24. Rushing EJ, Olsen C, Man YG. Correlation of p63 immunoreactivity with tumor grade in meningioma. Int J Surg Pathol. 2008; 16: 38–42. [PubMed] [Google Scholar]
25. Ghazy SE, Helmy IM, Baghdadi HM. Maspin and MCM2 immunoprofiling in salivary gland carcinomas. Diagn Pathol. 2011; 6: 89. [PMC free article] [PubMed] [Google Scholar]
26. Navarro Rde L, Martins MT, de Araújo VC. Maspin expression in normal and neoplastic salivary gland. J Oral Pathol Med. 2004; 33: 435–440. [PubMed] [Google Scholar]
27. Polyak K, Hu M. Do myoepithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia. 2005; 10: 231–247. [PubMed] [Google Scholar]
28. Taher MG, Abdullah BH, Al-Kari LE. Expression of MMP-2 as biological markers of invasion potential in mucoepidermoid carcinoma of the oral and maxillofacial region (immunohistochemical study) Diyala J Med. 2012; 3: 67–72. [Google Scholar]
29. Celardo I, Antonov A, Amelio I, Annicchiarico-Petruzzelli M, Melino G. P63 transcriptionally regulates the expression of matrix metallopeptidase 13. Oncotarget. 2014; 5: 1279–1789. [PMC free article] [PubMed] [Google Scholar] | ||
آمار تعداد مشاهده مقاله: 2,613 تعداد دریافت فایل اصل مقاله: 1,708 |